Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients

NCT02831530 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Abemaciclib

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris